OpenURL Connection Search

Select item for more details and to access through your institution.

A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2020, v. 38, n. 6, p. 1815, doi. 10.1007/s10637-020-00960-z
By:
- Lemech, Charlotte;
- Woodward, Natasha;
- Chan, Nancy;
- Mortimer, Joanne;
- Naumovski, Louie;
- Nuthalapati, Silpa;
- Tong, Bo;
- Jiang, Fang;
- Ansell, Peter;
- Ratajczak, Christine K.;
- Sachdev, Jasgit
Publication type:
Article
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR.
Published in:
Investigational New Drugs, 2020, v. 38, n. 5, p. 1483, doi. 10.1007/s10637-020-00908-3
By:
- Cleary, James M.;
- Calvo, Emiliano;
- Moreno, Victor;
- Juric, Dejan;
- Shapiro, Geoffrey I.;
- Vanderwal, Carol Ann;
- Hu, Beibei;
- Gifford, Maryella;
- Barch, David;
- Roberts-Rapp, Lisa;
- Ansell, Peter J.;
- Xiong, Hao;
- Ocampo, Christopher;
- Tolcher, Anthony W.
Publication type:
Article
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer.
Published in:
Investigational New Drugs, 2018, v. 36, n. 5, p. 828, doi. 10.1007/s10637-017-0551-z
By:
- van der Biessen, Diane A. J.;
- Gietema, Jourik A.;
- de Jonge, Maja J. A.;
- Desar, Ingrid M. E.;
- den Hollander, Martha W.;
- Dudley, Matthew;
- Dunbar, Martin;
- Hetman, Robert;
- Serpenti, Camille;
- Xiong, Hao;
- Mittapalli, Rajendar K.;
- Timms, Kirsten M.;
- Ansell, Peter;
- Ratajczak, Christine K.;
- Shepherd, Stacie Peacock;
- van Herpen, Carla M. L.
Publication type:
Article
Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies.
Published in:
Investigational New Drugs, 2015, v. 33, n. 4, p. 870, doi. 10.1007/s10637-015-0242-6
By:
- Garcia-Manero, Guillermo;
- Tibes, Raoul;
- Kadia, Tapan;
- Kantarjian, Hagop;
- Arellano, Martha;
- Knight, Emily;
- Xiong, Hao;
- Qin, Qin;
- Munasinghe, Wijith;
- Roberts-Rapp, Lisa;
- Ansell, Peter;
- Albert, Daniel;
- Oliver, Brian;
- McKee, Mark;
- Ricker, Justin;
- Khoury, Hanna
Publication type:
Article
A phase 1 study of ABT-806 in subjects with advanced solid tumors.
Published in:
Investigational New Drugs, 2015, v. 33, n. 3, p. 671, doi. 10.1007/s10637-015-0234-6
By:
- Cleary, James;
- Reardon, David;
- Azad, Nilofer;
- Gandhi, Leena;
- Shapiro, Geoffrey;
- Chaves, Jorge;
- Pedersen, Michelle;
- Ansell, Peter;
- Ames, William;
- Xiong, Hao;
- Munasinghe, Wijith;
- Dudley, Matt;
- Reilly, Edward;
- Holen, Kyle;
- Humerickhouse, Rod
Publication type:
Article
The Effects of SOM230 on Cell Proliferation and Adrenocorticotropin Secretion in Human Corticotroph Pituitary Adenomas.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 11, p. 4482, doi. 10.1210/jc.2006-1245
By:
- Batista, Dalia L.;
- Xun Zhang;
- Gejman, Roger;
- Ansell, Peter J.;
- Yunli Zhou;
- Johnson, Sarah A.;
- Swearingen, Brooke;
- Hedley-Whyte, E. Tessa;
- Stratakis, Constantine A.;
- Klibanski, Anne
Publication type:
Article
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification.
Published in:
2016
By:
- Jieyi Wang;
- Goetsch, Liliane;
- Tucker, Lora;
- Qian Zhang;
- Gonzalez, Alexandra;
- Vaidya, Kedar S.;
- Oleksijew, Anatol;
- Boghaert, Erwin;
- Minghao Song;
- Sokolova, Irina;
- Pestova, Ekaterina;
- Anderson, Mark;
- Pappano, William N.;
- Ansell, Peter;
- Bhathena, Anahita;
- Naumovski, Louie;
- Corvaia, Nathalie;
- Reilly, Edward B.;
- Wang, Jieyi;
- Zhang, Qian
Publication type:
journal article
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.
Published in:
NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00349-y
By:
- Metzger-Filho, Otto;
- Collier, Katharine;
- Asad, Sarah;
- Ansell, Peter J.;
- Watson, Mark;
- Bae, Junu;
- Cherian, Mathew;
- O'Shaughnessy, Joyce;
- Untch, Michael;
- Rugo, Hope S.;
- Huober, Jens B.;
- Golshan, Mehra;
- Sikov, William M.;
- von Minckwitz, Gunter;
- Rastogi, Priya;
- Li, Lang;
- Cheng, Lijun;
- Maag, David;
- Wolmark, Norman;
- Denkert, Carsten
Publication type:
Article
The ChEMBL database as linked open data.
Published in:
Journal of Cheminformatics, 2013, v. 5, n. 1, p. 1, doi. 10.1186/1758-2946-5-23
By:
- Willighagen, Egon L.;
- Waagmeester, Andra;
- Spjuth, Ola;
- Ansell, Peter;
- Williams, Antony J.;
- Tkachenko, Valery;
- Hastings, Janna;
- Chen, Bin;
- Wild, David J.
Publication type:
Article
Defining EGFR amplification status for clinical trial inclusion.
Published in:
Neuro-Oncology, 2019, v. 21, n. 10, p. 1263, doi. 10.1093/neuonc/noz096
By:
- French, Pim J;
- Eoli, Marica;
- Sepulveda, Juan Manuel;
- Heer, Iris de;
- Kros, Johan M;
- Walenkamp, Annemiek;
- Frenel, Jean-Sebastien;
- Franceschi, Enrico;
- Clement, Paul M;
- Weller, Michael;
- Ansell, Peter;
- Looman, Jim;
- Bain, Earle;
- Morfouace, Marie;
- Gorlia, Thierry;
- van den Bent, Martin
Publication type:
Article
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 106, doi. 10.1093/neuonc/noy091
By:
- Lassman, Andrew B;
- Bent, Martin J van den;
- Gan, Hui K;
- Reardon, David A;
- Kumthekar, Priya;
- Butowski, Nicholas;
- Lwin, Zarnie;
- Mikkelsen, Tom;
- Nabors, Louis B;
- Papadopoulos, Kyriakos P;
- Penas-Prado, Marta;
- Simes, John;
- Wheeler, Helen;
- Walbert, Tobias;
- Scott, Andrew M;
- Gomez, Erica;
- Lee, Ho-Jin;
- Roberts-Rapp, Lisa;
- Xiong, Hao;
- Ansell, Peter J
Publication type:
Article
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.
Published in:
Neuro-Oncology, 2018, v. 20, n. 6, p. 838, doi. 10.1093/neuonc/nox202
By:
- Gan, Hui K.;
- Reardon, David A.;
- Lassman, Andrew B.;
- Merrell, Ryan;
- van den Bent, Martin;
- Butowski, Nicholas;
- Lwin, Zarnie;
- Wheeler, Helen;
- Fichtel, Lisa;
- Scott, Andrew M.;
- Gomez, Erica J.;
- Fischer, JuDee;
- Mandich, Helen;
- Hao Xiong;
- Ho-Jin Lee;
- Munasinghe, Wijith P.;
- Roberts-Rapp, Lisa A.;
- Ansell, Peter J.;
- Holen, Kyle D.;
- Kumthekar, Priya
Publication type:
Article
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.
Published in:
Neuro-Oncology, 2017, v. 19, n. 7, p. 965, doi. 10.1093/neuonc/now257
By:
- Reardon, David A.;
- Lassman, Andrew B.;
- van den Bent, Martin;
- Kumthekar, Priya;
- Merrell, Ryan;
- Scott, Andrew M.;
- Fichtel, Lisa;
- Sulman, Erik P.;
- Gomez, Erica;
- Fischer, JuDee;
- Ho-Jin Lee;
- Munasinghe, Wijith;
- Hao Xiong;
- Mandich, Helen;
- Roberts-Rapp, Lisa;
- Ansell, Peter;
- Holen, Kyle D.;
- Gan, Hui K.
Publication type:
Article
ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition.
Published in:
2021
By:
- Anderson, Mark G.;
- Zhang, Qian;
- Rodriguez, Luis E.;
- Hecquet, Claudie M.;
- Donawho, Cherrie K.;
- Ansell, Peter J.;
- Reilly, Edward B.
Publication type:
journal article
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.
Published in:
2018
By:
- Maitland, Michael L.;
- Piha-Paul, Sarina;
- Falchook, Gerald;
- Kurzrock, Razelle;
- Nguyen, Ly;
- Janisch, Linda;
- Karovic, Sanja;
- McKee, Mark;
- Hoening, Elizabeth;
- Wong, Shekman;
- Munasinghe, Wijith;
- Palma, Joann;
- Donawho, Cherrie;
- Lian, Guinan K.;
- Ansell, Peter;
- Ratain, Mark J.;
- Hong, David
Publication type:
journal article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Gan, Hui K.;
- Burge, Matthew;
- Solomon, Benjamin;
- Lee, Sze Ting;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Gan, Hui K.;
- Burge, Matthew;
- Solomon, Benjamin;
- Sze Ting Lee;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Gan, Hui K.;
- Burge, Matthew;
- Solomon, Benjamin;
- Sze Ting Lee;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Hui K. Gan;
- Burge, Matthew;
- Solomon, Benjamin;
- Sze Ting Lee;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Hui K. Gan;
- Burge, Matthew;
- Solomon, Benjamin;
- Sze Ting Lee;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Hui K. Gan;
- Burge, Matthew;
- Solomon, Benjamin;
- Sze Ting Lee;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Gan, Hui K.;
- Burge, Matthew;
- Solomon, Benjamin;
- Sze Ting Lee;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Gan, Hui K.;
- Burge, Matthew;
- Solomon, Benjamin;
- Sze Ting Lee;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.253146
By:
- Gan, Hui K.;
- Burge, Matthew;
- Solomon, Benjamin;
- Lee, Sze Ting;
- Holen, Kyle D.;
- Yumin Zhang;
- Ciprotti, Marika;
- Lee, F. T.;
- Munasinghe, Wijith;
- Fischer, JuDee;
- Ansell, Peter;
- Fox, Gerard;
- Hao Xiong;
- Reilly, Edward B.;
- Humerickhouse, Rod;
- Scott, Andrew M.
Publication type:
Article
An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1477, doi. 10.1007/s00280-012-1846-6
By:
- Asahina, Hajime;
- Tamura, Yosuke;
- Nokihara, Hiroshi;
- Yamamoto, Noboru;
- Seki, Yoshitaka;
- Shibata, Takashi;
- Goto, Yasushi;
- Tanioka, Maki;
- Yamada, Yasuhide;
- Coates, Andrew;
- Chiu, Yi-Lin;
- Li, Xiaohui;
- Pradhan, Rajendra;
- Ansell, Peter;
- McKeegan, Evelyn;
- McKee, Mark;
- Carlson, Dawn;
- Tamura, Tomohide
Publication type:
Article
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma.
Published in:
Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdac183
By:
- Carneiro, Benedito A;
- Papadopoulos, Kyriakos P;
- Strickler, John H;
- Lassman, Andrew B;
- Waqar, Saiama N;
- Chae, Young Kwang;
- Patel, Jyoti D;
- Shacham-Shmueli, Einat;
- Kelly, Karen;
- Khasraw, Mustafa;
- Bestvina, Christine M;
- Merrell, Ryan;
- Huang, Kevin;
- Atluri, Harisha;
- Ansell, Peter;
- Li, Rachel;
- Jin, Janet;
- Anderson, Mark G;
- Reilly, Edward B;
- Morrison-Thiele, Gladys
Publication type:
Article
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer.
Published in:
2022
By:
- Zhang, Bingnan;
- Stewart, C. Allison;
- Wang, Qi;
- Cardnell, Robert J.;
- Rocha, Pedro;
- Fujimoto, Junya;
- Solis Soto, Luisa M.;
- Wang, Runsheng;
- Novegil, Veronica;
- Ansell, Peter;
- He, Lei;
- Fernandez, Luisa;
- Jendrisak, Adam;
- Gilbertson, Cole;
- Schonhoft, Joseph D.;
- Byun, Jiyun;
- Jones, Joshua;
- Anderson, Amanda K. L.;
- Aparicio, Ana;
- Tran, Hai
Publication type:
journal article
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
Published in:
2018
By:
- Goss, Glenwood D.;
- Vokes, Everett E.;
- Gordon, Michael S.;
- Gandhi, Leena;
- Papadopoulos, Kyriakos P.;
- Rasco, Drew W.;
- Fischer, JuDee S.;
- Chu, Katharine L.;
- Ames, William W.;
- Mittapalli, Rajendar K.;
- Lee, Ho‐Jin;
- Zeng, Jiewei;
- Roberts‐Rapp, Lisa A.;
- Loberg, Lise I.;
- Ansell, Peter J.;
- Reilly, Edward B.;
- Ocampo, Christopher J.;
- Holen, Kyle D.;
- Tolcher, Anthony W.;
- Lee, Ho-Jin
Publication type:
journal article
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma.
Published in:
Cancer (0008543X), 2013, v. 119, n. 2, p. 380, doi. 10.1002/cncr.27758
By:
- Toh, Han Chong;
- Chen, Pei‐Jer;
- Carr, Brian I.;
- Knox, Jennifer J.;
- Gill, Sharlene;
- Ansell, Peter;
- McKeegan, Evelyn M.;
- Dowell, Barry;
- Pedersen, Michelle;
- Qin, Qin;
- Qian, Jiang;
- Scappaticci, Frank A.;
- Ricker, Justin L.;
- Carlson, Dawn M.;
- Yong, Wei Peng
Publication type:
Article
Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR.
Published in:
Journal of Neuro-Oncology, 2021, v. 152, n. 2, p. 233, doi. 10.1007/s11060-021-03703-z
By:
- Vaidya, Kedar S.;
- Mitten, Michael J.;
- Zelaya-Lazo, Adelyn L.;
- Oleksijew, Anatol;
- Alvey, Cory;
- Falls, Hugh D.;
- Mishra, Sasmita;
- Palma, Joann;
- Ansell, Peter;
- Phillips, Andrew C.;
- Reilly, Edward B.;
- Anderson, Mark;
- Boghaert, Erwin R.
Publication type:
Article
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
Published in:
Journal of Neuro-Oncology, 2019, v. 144, n. 1, p. 205, doi. 10.1007/s11060-019-03222-y
By:
- Lassman, Andrew B.;
- Aldape, Kenneth D.;
- Ansell, Peter J.;
- Bain, Earle;
- Curran, Walter J.;
- Eoli, Marica;
- French, Pim J.;
- Kinoshita, Manabu;
- Looman, Jim;
- Mehta, Minesh;
- Muragaki, Yoshihiro;
- Narita, Yoshitaka;
- Ocampo, Christopher;
- Roberts-Rapp, Lisa;
- Song, Minghao;
- Vogelbaum, Michael A.;
- Walenkamp, Annemiek M. E.;
- Wang, Tony J. C.;
- Zhang, Peixin;
- van den Bent, Martin J.
Publication type:
Article
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Published in:
Neuro-Oncology, 2023, v. 25, n. 2, p. 339, doi. 10.1093/neuonc/noac173
By:
- Lassman, Andrew B;
- Pugh, Stephanie L;
- Wang, Tony J C;
- Aldape, Kenneth;
- Gan, Hui K;
- Preusser, Matthias;
- Vogelbaum, Michael A;
- Sulman, Erik P;
- Won, Minhee;
- Zhang, Peixin;
- Moazami, Golnaz;
- Macsai, Marian S;
- Gilbert, Mark R;
- Bain, Earle E;
- Blot, Vincent;
- Ansell, Peter J;
- Samanta, Suvajit;
- Kundu, Madan G;
- Armstrong, Terri S;
- Wefel, Jeffrey S
Publication type:
Article

Found: 32